Liposomal Docetaxel for Agricultural, Veterinary, and Aquatic Applications

Publication ID: 24-11857680_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Liposomal Docetaxel for Agricultural, Veterinary, and Aquatic Applications,” Published Technical Disclosure No. 24-11857680_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857680_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,680.

Summary of the Inventive Concept

The present inventive concept relates to novel applications of liposomal docetaxel compositions for pest control, fungal disease treatment, and cancer treatment in various industries, including agriculture, veterinary medicine, and aquaculture.

Background and Problem Solved

The original patent disclosed a liposomal composition of docetaxel for cancer treatment, but its potential uses were limited to the pharmaceutical industry. The present inventive concept addresses the need for innovative solutions in other industries, where the unique properties of liposomal docetaxel can provide effective and targeted treatments.

Detailed Description of the Inventive Concept

The new claims describe liposomal compositions of docetaxel tailored for specific industries, including agricultural pest control, veterinary cancer treatment, and aquatic disease treatment. These compositions leverage the original patent's high drug loading and targeting capabilities, while incorporating industry-specific requirements, such as pH adjustments and solubilizers. The inventive concept encompasses systems and methods for delivering docetaxel to pests, plants, companion animals, and aquatic organisms, offering a range of benefits, including increased efficacy, reduced toxicity, and improved environmental sustainability.

Novelty and Inventive Step

The new claims introduce novel applications of liposomal docetaxel, which were not contemplated in the original patent. The inventive step lies in the adaptation of the original composition to new industries, requiring specific modifications and optimizations to address distinct challenges and needs.

Alternative Embodiments and Variations

Alternative embodiments may include varying the liposomal composition's pH, solubilizers, or docetaxel concentrations to suit different industries or specific use cases. Variations could also involve incorporating additional components, such as targeting moieties or synergistic agents, to enhance the composition's efficacy or selectivity.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the agricultural, veterinary, and aquaculture industries, offering innovative solutions for pest control, disease treatment, and cancer therapy. The target market includes companies involved in crop protection, animal health, and aquaculture, as well as research institutions and government agencies focused on sustainable and environmentally friendly practices.

CPC Classifications

SectionClassGroup
A A61 A61K9/127
A A61 A61K9/0019
A A61 A61K9/1277
A A61 A61K31/337
A A61 A61K47/24
A A61 A61K47/26
A A61 A61K47/28

Original Patent Information

Patent NumberUS 11,857,680
TitleComposition of docetaxel liposomal injection with high drug loading
Assignee(s)SHILPA MEDICARE LIMITED